Cimetadine Hydrochloride Oral Solution 300mg/5ml
Company: Morton Grove Pharmaceuticals
Approval Status: Approved October 1997
Treatment for: gastric ulcer and GERD
Areas: Gastroenterology
General Information
Other Useful Resources
Cimetadine Hydrochloride Oral Solution 300mg/5ml has been approved for the treatment of duodenal ulcer, gastric ulcer, GERD, gastrointestinal bleeding, and pathological hypersecretory conditions. Cimetadine Hydrochloride Oral Solution 300mg/5ml is the generic equivalent of TAGAMET Oral Solution marketed by SmithKline Beecham.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
